nach oben

Current Diabetes Reports

Erschienen in:

01.09.2019 | Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors)

Genetics of Diabetic Retinopathy

verfasst von: Jonathan Han, Leonardo Lando, Dorota Skowronska-Krawczyk, Daniel L. Chao

Erschienen in: Current Diabetes Reports | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The goal of this paper is to review the latest findings in understanding the genetics of diabetic retinopathy. We highlight recent literature using a variety of molecular genetic techniques to identify variants which contribute to genetic susceptibility for diabetic retinopathy.

Recent Findings

New genome-wide association study (GWAS) and whole-exome sequencing approaches have been utilized to identify both common and rare variants associated with diabetic retinopathy. While variants have been identified in isolated studies, no variants have been replicated across multiple studies.

Summary

The identification of genetic factors associated with diabetic retinopathy remains elusive. This is due to the multifactorial nature of the disease, small sample sizes for GWAS, and difficulty in controlling covariates of the disease. Larger populations as well as utilization of new sequencing and data analysis techniques may lead to new insights into genetic factors associated with diabetic retinopathy in the future.

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17. https://doi.org/10.1186/s40662-015-0026-2.CrossRef

Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e34. https://doi.org/10.1016/S2214-109X(17)30393-5. CrossRefPubMed

Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77. https://doi.org/10.1111/ceo.12696.CrossRefPubMed

Pyke DA, Tattersall RB. Diabetic retinopathy in identical twins. Diabetes. 1973;22(8):613–8. https://doi.org/10.2337/diab.22.8.613.CrossRefPubMed

Leslie RD, Pyke DA. Diabetic retinopathy in identical twins. Diabetes. 1982;31(1):19–21. https://doi.org/10.2337/diab.31.1.19.CrossRefPubMed

Diabetes mellitus in twins: a cooperative study in Japan. Committee on Diabetic Twins, Japan Diabetes Society. Diabetes Res Clin Pract. 1988;5(4):271–80.

Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997;46(11):1829–39.

Arar NH, Freedman BI, Adler SG, Iyengar SK, Chew EY, Davis MD, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49(9):3839–45. https://doi.org/10.1167/iovs.07-1633.CrossRefPubMedPubMedCentral

Hietala K, Forsblom C, Summanen P, Groop PH, FinnDiane Study G. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57(8):2176–80. https://doi.org/10.2337/db07-1495.CrossRefPubMedPubMedCentral

10.

Cantor RM. Model-based linkage analysis of a binary trait. Methods Mol Biol. 2017;1666:311–26. https://doi.org/10.1007/978-1-4939-7274-6_15.CrossRefPubMed

11.

Cho H, Sobrin L. Genetics of diabetic retinopathy. Curr Diab Rep. 2014;14(8):515. https://doi.org/10.1007/s11892-014-0515-z.CrossRefPubMedPubMedCentral

12.

Tang ZH, Wang L, Zeng F, Zhang K. Human genetics of diabetic retinopathy. J Endocrinol Investig. 2014;37(12):1165–74. https://doi.org/10.1007/s40618-014-0172-8.CrossRef

13.

Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes. 1998;47(5):821–830.CrossRef

14.

Looker HC, Nelson RG, Chew E, Klein R, Klein BE, Knowler WC, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes. 2007;56(4):1160–6. https://doi.org/10.2337/db06-1299.CrossRefPubMed

15.

Hallman DM, Boerwinkle E, Gonzalez VH, Klein BE, Klein R, Hanis CL. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes. 2007;56(4):1167–73. https://doi.org/10.2337/db06-1373.CrossRefPubMed

16.

Dawn Teare M, Barrett JH. Genetic linkage studies. Lancet. 2005;366(9490):1036–44. https://doi.org/10.1016/S0140-6736(05)67382-5.CrossRefPubMed

17.

Kwon JM, Goate AM. The candidate gene approach. Alcohol Res Health. 2000;24(3):164–8.PubMed

18.

Petrovic D. Candidate genes for proliferative diabetic retinopathy. Biomed Res Int. 2013;2013:540416. https://doi.org/10.1155/2013/540416.CrossRefPubMedPubMedCentral

19.

Priscakova P, Minarik G, Repiska V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016;43(12):1327–45. https://doi.org/10.1007/s11033-016-4075-y.CrossRefPubMedPubMedCentral

20.

Sharma A, Valle ML, Beveridge C, Liu Y, Sharma S. Unraveling the role of genetics in the pathogenesis of diabetic retinopathy. Eye (Lond). 2019;33(4):534–41. https://doi.org/10.1038/s41433-019-0337-y.CrossRef

21.

Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy. JAMA Ophthalmol. 2014;132(1):96–107. https://doi.org/10.1001/jamaophthalmol.2013.5024.CrossRefPubMedPubMedCentral

22.

Chen CF, Liou SW, Wu HH, Lin CH, Huang LS, Woung LC, et al. Regulatory SNPs Alter the gene expression of diabetic retinopathy associated secretary factors. Int J Med Sci. 2016;13(9):717–23. https://doi.org/10.7150/ijms.16345.CrossRefPubMedPubMedCentral

23.

Qiu M, Xiong W, Liao H, Li F. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis. Gene. 2013;518(2):310–5. https://doi.org/10.1016/j.gene.2013.01.018.CrossRefPubMed

24.

Lu Y, Ge Y, Shi Y, Yin J, Huang Z. Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: an updated meta-analysis. BMC Ophthalmol. 2013;13:56. https://doi.org/10.1186/1471-2415-13-56.CrossRefPubMedPubMedCentral

25.

Han L, Zhang L, Xing W, Zhuo R, Lin X, Hao Y, et al. The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies. J Diabetes Res. 2014;2014:805801. https://doi.org/10.1155/2014/805801.CrossRefPubMedPubMedCentral

26.

Xie XJ, Yang YM, Jiang JK, Lu YQ. Association between the vascular endothelial growth factor single nucleotide polymorphisms and diabetic retinopathy risk: a meta-analysis. J Diabetes. 2017;9(8):738–53. https://doi.org/10.1111/1753-0407.12480.CrossRefPubMed

27.

Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038. https://doi.org/10.1155/2007/61038.CrossRefPubMedPubMedCentral

28.

Engerman RL. Pathogenesis of diabetic retinopathy. Diabetes. 1989;38(10):1203–6. https://doi.org/10.2337/diab.38.10.1203.CrossRefPubMed

29.

Abhary S, Hewitt AW, Burdon KP, Craig JE. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes. 2009;58(9):2137–47. https://doi.org/10.2337/db09-0059.CrossRefPubMedPubMedCentral

30.

Ng DP. Human genetics of diabetic retinopathy: current perspectives. J Ophthalmol. 2010;2010:1–6. https://doi.org/10.1155/2010/172593.CrossRef

31.

Saxena R, Singh D, Saklani R, Gupta SK. Clinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects. Eye Brain. 2016;8:1–13. https://doi.org/10.2147/EB.S69185.CrossRefPubMedPubMedCentral

32.

Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS. Updates on aldose reductase inhibitors for management of diabetic complications and non-diabetic diseases. Mini Rev Med Chem. 2016;16(2):120–62.CrossRef

33.

•• Sobrin L, Green T, Sim X, Jensen RA, Tai ES, Tay WT, et al. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci. 2011;52(10):7593–602. https://doi.org/10.1167/iovs.11-7510. Largest candidate gene study done for diabetic retinopathy. CrossRefPubMedPubMedCentral

34.

Dehghan A. Genome-wide association studies. Methods Mol Biol. 2018;1793:37–49. https://doi.org/10.1007/978-1-4939-7868-7_4.CrossRefPubMed

35.

Chang M, He L, Cai L. An overview of genome-wide association studies. Methods Mol Biol. 2018;1754:97–108. https://doi.org/10.1007/978-1-4939-7717-8_6.CrossRefPubMed

36.

Fadista J, Manning AK, Florez JC, Groop L. The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants. Eur J Hum Genet. 2016;24(8):1202–5. https://doi.org/10.1038/ejhg.2015.269.CrossRefPubMedPubMedCentral

37.

Kanai M, Tanaka T, Okada Y. Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set. J Hum Genet. 2016;61(10):861–6. https://doi.org/10.1038/jhg.2016.72.CrossRefPubMedPubMedCentral

38.

Awata T, Yamashita H, Kurihara S, Morita-Ohkubo T, Miyashita Y, Katayama S, et al. A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. PLoS One. 2014;9(11):e111715. https://doi.org/10.1371/journal.pone.0111715.CrossRefPubMedPubMedCentral

39.

Burdon KP, Fogarty RD, Shen W, Abhary S, Kaidonis G, Appukuttan B, et al. Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia. 2015;58(10):2288–97. https://doi.org/10.1007/s00125-015-3697-2.CrossRefPubMed

40.

• Graham PS, Kaidonis G, Abhary S, Gillies MC, Daniell M, Essex RW, et al. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy. BMC Med Genet. 2018;19(1):71. https://doi.org/10.1186/s12881-018-0587-8. A study showing that different aspects of diabetic retinopathy and diabetic macular edema may have differing genetic suceptibility. CrossRefPubMedPubMedCentral

41.

Meng W, Shah KP, Pollack S, Toppila I, Hebert HL, McCarthy MI, et al. A genome-wide association study suggests new evidence for an association of the NADPH oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes. Acta Ophthalmol. 2018;96(7):e811–e9. https://doi.org/10.1111/aos.13769. CrossRefPubMedPubMedCentral

42.

•• Pollack S, Igo RP Jr, Jensen RA, Christiansen M, Li X, Cheng CY, et al. Multiethnic genome-wide association study of diabetic retinopathy using liability threshold modeling of duration of diabetes and glycemic control. Diabetes. 2019;68(2):441–56. https://doi.org/10.2337/db18-0567. The largest and well-designed GWAS performed on diabetic retinopathy. CrossRefPubMed

43.

• Shtir C, Aldahmesh MA, Al-Dahmash S, Abboud E, Alkuraya H, Abouammoh MA et al. Exome-based case-control association study using extreme phenotype design reveals novel candidates with protective effect in diabetic retinopathy. Hum Genet 2016;135(2):193–200. doi:10.1007/s00439-015-1624-8. Use of whole-exome approach using extreme phenotyping to identify rare variants associated with diabetic retinopathy. CrossRef

44.

• Ung C, Sanchez AV, Shen L, Davoudi S, Ahmadi T, Navarro-Gomez D, et al. Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy. Vis Res. 2017;139:168–76. https://doi.org/10.1016/j.visres.2017.03.007. A whole-exome analysis using extreme phenotyping to identify rare variants associated with diabetic retinopathy. CrossRefPubMed

45.

De R, Bush WS, Moore JH. Bioinformatics challenges in genome-wide association studies (GWAS). Methods Mol Biol. 2014;1168:63–81. https://doi.org/10.1007/978-1-4939-0847-9_5.CrossRefPubMed

46.

Lalonde E, Albrecht S, Ha KC, Jacob K, Bolduc N, Polychronakos C, et al. Unexpected allelic heterogeneity and spectrum of mutations in Fowler syndrome revealed by next-generation exome sequencing. Hum Mutat. 2010;31(8):918–23. https://doi.org/10.1002/humu.21293.CrossRefPubMed

47.

Agarwal A, Ingham SA, Harkins KA, Do DV, Nguyen QD. The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy. Pharmacogenomics. 2016;17(3):309–20. https://doi.org/10.2217/pgs.15.173.CrossRefPubMed

48.

El-Shazly SF, El-Bradey MH, Tameesh MK. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes. Clin Exp Ophthalmol. 2014;42(4):369–78. https://doi.org/10.1111/ceo.12182.CrossRefPubMed

49.

Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51(5):1635–9. https://doi.org/10.2337/diabetes.51.5.1635.CrossRefPubMed

50.

Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, Inoue I, Kawasaki I, Mori K, Yoneya S, Katayama S Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 2005;333(3):679–685. doi:https://doi.org/10.1016/j.bbrc.2005.05.167.CrossRef

51.

Tetikoglu M, Yuksel Z, Aktas S, Sagdik HM, Ozcura F. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema. Int Ophthalmol. 2018;38(6):2381–8. https://doi.org/10.1007/s10792-017-0738-5.CrossRefPubMed

Titel: Genetics of Diabetic Retinopathy
verfasst von: Jonathan Han
Leonardo Lando
Dorota Skowronska-Krawczyk
Daniel L. Chao
Publikationsdatum: 01.09.2019
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 9/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-019-1186-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2019

Can the Routine Use of Patient-Reported Outcome Measures Improve the Delivery of Person-Centered Diabetes Care? A Review of Recent Developments and a Case Study

The Beta Cell in Type 2 Diabetes

Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection?

Rebuttals to “The Debate on Insulin vs. Non-insulin Use in the Hospital Setting—Continued Use of Insulin or Time to Revise the Guidelines?”

Nutritional Supplementation for the Prevention and/or Treatment of Gestational Diabetes Mellitus